Beijing SL Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Net Income	-348.21	-74.07	416.69	234.4	425.94
Depreciation & Amortization	166.78	152.94	145.4	113.88	99.8
Other Amortization	0.28	0.29	0.28	0.17	0.17
Loss (Gain) From Sale of Assets	0.05	-	-	-0.21	-3.22
Asset Writedown & Restructuring Costs	-326.35	-0	-0.01	0	0.02
Loss (Gain) From Sale of Investments	-13.38	159.17	-239.47	-98.13	-209.01
Provision & Write-off of Bad Debts	-	9.49	23.81	31.94	26.25
Other Operating Activities	621.15	0.94	1.05	-5.99	-4.38
Change in Accounts Receivable	-14.76	62.45	19.66	82.88	108.64
Change in Inventory	-436.26	-102.33	-4.25	0.58	-11.5
Change in Accounts Payable	544.68	68.51	66.58	36.56	17.54
Operating Cash Flow	257.66	225.49	460.2	389.82	464.63
Operating Cash Flow Growth	14.27%	-51.00%	18.05%	-16.10%	11.73%
Capital Expenditures	-192.97	-347.38	-218.36	-163.49	-236.91
Sale of Property, Plant & Equipment	0	0	0.01	1.47	7.49
Divestitures	-	-	-	-4.88	-
Investment in Securities	26.4	-33.46	-86.95	-384.76	-0.96
Other Investing Activities	27.29	169.29	-39.35	11.25	32.55
Investing Cash Flow	-139.28	-211.55	-344.65	-540.4	-197.82
Short-Term Debt Issued	-	-	-	-	5.5
Total Debt Issued	-	-	-	-	5.5
Short-Term Debt Repaid	-	-	-	-	-14.5
Long-Term Debt Repaid	-	-	-	-	-0.4
Total Debt Repaid	-	-	-	-	-14.9
Net Debt Issued (Repaid)	-	-	-	-	-9.4
Common Dividends Paid	-17.9	-154.1	-102.74	-102.74	-102.93
Other Financing Activities	-	-	-	-	9
Financing Cash Flow	-17.9	-154.1	-102.74	-102.74	-103.33
Foreign Exchange Rate Adjustments	0	-0	0.03	0.1	-0.02
Net Cash Flow	100.49	-140.17	12.84	-253.21	163.45
Free Cash Flow	64.69	-121.89	241.84	226.33	227.72
Free Cash Flow Growth	-	-	6.85%	-0.61%	42.42%
Free Cash Flow Margin	10.37%	-18.46%	23.75%	21.55%	18.75%
Free Cash Flow Per Share	0.06	-0.12	0.24	0.22	0.22
Cash Income Tax Paid	26.6	39.14	88.16	91.55	85.63
Levered Free Cash Flow	-156.43	-260.4	186.77	121.34	113.97
Unlevered Free Cash Flow	-156.43	-260.4	186.77	121.4	114.11
Change in Working Capital	157.34	-23.28	112.45	113.75	129.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.